Articles Tagged With: treatment
-
Flu Season Charts an Unusual Course, Beginning With a Predominant B Victoria Strain
Frontline providers confronted an unusual influenza season, with flu activity spiking as early as December. B virus strains, which usually lead to worse outcomes in children, was predominant in the early part of the season. By mid-February, flu activity remained widespread throughout the United States.
-
Work With Public Health Partners on Treatment, Care of Patients Diagnosed With COVID-19
The recommended care of a patient with COVID-19 is similar to what is required for other viral pneumonias, such as those associated with influenza or respiratory syncytial virus. Further, mild disease does not necessarily require hospitalization.
-
Frontline Providers Use Lessons Learned During 2014 Ebola Crisis to Manage COVID-19
Experts from the National Ebola Training and Education Center urge healthcare systems to adopt processes in line with “Identify, Isolate, and Inform,” a process for quickly identifying and managing cases of infectious disease in a way that minimizes the risk for subsequent transmissions.
-
Peanut (Arachis hypogaea) Allergen Powder-dnfp (Palforzia)
This is the first FDA-approved oral immunotherapy for desensitizing peanut allergy in children to help reduce the risk of allergic reactions.
-
Intravenous Immunoglobulin for Treatment of Autoimmune Epilepsies
Patients with LGI1 and CASPR2 IgG-associated autoimmune epilepsy were identified and randomized to treatment with intravenous immunoglobulin (IVIG) vs. placebo. The authors hypothesized that IVIG would show superiority over placebo, with a primary endpoint of 50% or greater seizure reduction.
-
Status Epilepticus
Status epilepticus is a serious medical condition that is defined as a seizure lasting longer than five minutes or more than one seizure without recovery to baseline between seizures.
-
Cefiderocol (Fetroja)
Cefiderocol is a novel siderophore cephalosporin with a wide spectrum of activity against difficult-to-treat gram-negative organisms for which there currently are limited treatment options.
-
Epilepsy Management in Primary Care
Epilepsy affects about 50 million people worldwide and is responsible for up to 0.5% of the global burden of disease. There are more than 5 million people diagnosed with epilepsy every year and that number is expected to continue to rise.
-
Indiana Patients Turning to EDs for Opioid Use Disorder Assistance
The rate of such encounters skyrocketed over five years; researchers search for answers.
-
Rate of Medicare Beneficiaries Hospitalized for Sepsis Jumps
Investigators observed a 40% increase between 2012 and 2018.